NPI: 1528027349 · LODI, CA 95242 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/21/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 03/21/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,852 | $798K |
| 2019 | 11,151 | $871K |
| 2020 | 13,062 | $939K |
| 2021 | 6,155 | $794K |
| 2022 | 5,946 | $890K |
| 2023 | 10,626 | $1.33M |
| 2024 | 5,292 | $1.12M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,201 | 3,224 | $6.73M |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,073 | 636 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 2,897 | 853 | $944.65 |
| A4657 | Syringe, with or without needle, each | 2,501 | 1,168 | $598.05 |
| 0250 | 2,225 | 143 | $471.28 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 284 | 175 | $242.20 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,812 | 813 | $238.26 |
| J1644 | Injection, heparin sodium, per 1000 units | 13 | 12 | $0.00 |
| 90674 | 35 | 33 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 43 | 36 | $0.00 |